Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection

Details for Australian Patent Application No. 2011202860 (hide)

Owner Emory University Sloan-Kettering Institute for Cancer Research

Inventors Kalman, Daniel; Bornmann, William Gerard; Sherman, Melanie Anne; Reeves, Patrick Michael; Swimm, Alyson Irene

Agent Pizzeys

Pub. Number AU-A-2011202860

Parent 2005209231

Filing date 15 June 2011

Wipo publication date 7 July 2011

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

30 June 2011 Complete Application Filed

7 July 2011 Application Open to Public Inspection

  Published as AU-A-2011202860

7 July 2011 Corrigenda

  Complete Applications Filed - Name Index Under the name Emory University; SloanKettering Institute for Cancer Research., Application No. 2011202860, under INID (71) correct the applicant name to Sloan-Kettering Institute for Cancer Research

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202861-Colorimetric substrates, colorimetric sensors, and methods of use

2011202859-Mechanically modified filter cake